Answers are grounded in this paper and cite their sources.
In severe chest wall injury, even in the absence of clinical flail chest, the majority of patients still reported moderate to extreme pain and impairment of usual physical activity at one month. SSRF increased hospital LOS and did not provide any quality of life benefit for up to 6 months.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: